These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26327627)

  • 21. Influence of PVP/VA copolymer composition on drug-polymer solubility.
    Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
    Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and Characterization of Co-Processed Mannitol and Sorbitol Using NanoCrySP Technology.
    Rao SG; Parmar PK; Reddy KV; Bansal AK
    AAPS PharmSciTech; 2021 Jul; 22(5):201. PubMed ID: 34231193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P
    Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
    Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
    Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permeability Behavior of Nanocrystalline Solid Dispersion of Dipyridamole Generated Using NanoCrySP Technology.
    Girdhar A; Thakur PS; Sheokand S; Bansal AK
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30227673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of Ophthalmic Nanosuspension of Prednisolone Acetate Using a Novel Technology.
    Nandwani Y; Kaur A; Bansal AK
    Pharm Res; 2021 Feb; 38(2):319-333. PubMed ID: 33560484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
    Kayaert P; Van den Mooter G
    Eur J Pharm Biopharm; 2012 Aug; 81(3):650-6. PubMed ID: 22579733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of protein on mannitol polymorphic form produced during co-spray drying.
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of celecoxib nanoparticles from volatile microemulsions.
    Margulis-Goshen K; Kesselman E; Danino D; Magdassi S
    Int J Pharm; 2010 Jun; 393(1-2):230-7. PubMed ID: 20403417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
    Fong SY; Ibisogly A; Bauer-Brandl A
    Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.
    Knopp MM; Nguyen JH; Mu H; Langguth P; Rades T; Holm R
    AAPS J; 2016 Mar; 18(2):416-23. PubMed ID: 26769250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
    Zajc N; Obreza A; Bele M; Srcic S
    Int J Pharm; 2005 Mar; 291(1-2):51-8. PubMed ID: 15707731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    J Pharm Sci; 2015 Sep; 104(9):3018-28. PubMed ID: 25195539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F; Huang J; Hussain MA
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.